Skip to main content
. 2011 Jan 3;79(3):1194–1207. doi: 10.1128/IAI.01031-10

TABLE 1.

Strains examined in this study and summary of genotyping and virulence data

Strain Sourcea rrn type vcg genotype rep-PCR Capsule PCR Lineage MLST Virulence group No. with skin infection/totalb Skin CFU count/g (log10)c No. with liver infection/totalb Liver CFU count/g (log10)c No. dead/totalb Temp (°C)c
2400112 C B C 3 4 5/5 7.7 ± 1.2 5/5 5.0 ± 1.9 3/5 32.5 ± 1.7
106-2A E B C NGd 2 3 4/5 6.9 ± 1.8 0/5 2.2 ± 0.1 0/5 37.8 ± 0.4
246-0058 Cape Canaveral C A E 7 0 3 5/5 6.8 ± 2.2 0/5 2.5 ± 0.0 0/5 36.1 ± 1.1
98-640 DP-E9 E A E 4 2 2 1 2 3/5 6.0 ± 2.8 0/5 2.5 ± 0.0 0/5 35.9 ± 0.7
98-641 DP-G8 E AB E 4 2 1 2 4/5 6.5 ± 2.5 0/5 2.5 ± 0.0 0/5 34.5 ± 0.6
98-783 DP-A1 E A E 4 1 1 2 3/4 6.3 ± 2.2 0/4 2.5 ± 0.0 1/4 34.5 ± 1.3
99-505 DP-C8 E AB E 4 2 1 2 5/5 6.2 ± 2.1 2/5 3.2 ± 0.9 1/5 34.6 ± 1.4
99-509 DP-A6 E A E 4 1 2 4 8/10 6.7 ± 2.3 7/10 4.8 ± 2.4 4/10 33.5 ± 2.7
99-520 DP-B8 E AB E 4 2 1 3 5/5 7.9 ± 0.6 0/5 2.5 ± 0.0 0/5 36.3 ± 0.4
99-537 DP-G7 E A E 4 2 1 3 5/5 8.2 ± 0.3 2/5 3.0 ± 0.7 0/5 37.2 ± 1.2
99-540 DP-B6 E A E 4 2 2 1 3 5/5 7.7 ± 0.4 0/5 2.5 ± 0.0 0/5 36.3 ± 0.6
99-578 DP-B1 E B C 3 1 2 4 5/5 7.9 ± 0.2 4/5 4.9 ± 1.4 4/5 32.3 ± 1.9
99-581 DP-C7 E A E 6 2 1 3 5/5 7.2 ± 0.6 2/5 3.0 ± 0.6 0/5 36.8 ± 0.3
99-584 DP-B12 E A E 4 2 1 2 4/10 4.6 ± 2.0 0/10 2.5 ± 0.0 0/10 35.2 ± 1.2
99-609 DP-A4 E A E 4 2 2 1 3 5/5 7.9 ± 0.4 3/5 2.8 ± 0.3 1/5 35.1 ± 1.8
99-622 DP-E4 E A E 4 2 1 4 5/5 7.7 ± 0.3 2/5 3.6 ± 1.6 0/5 34.1 ± 1.1
99-623 DP-F5 E AB E 4 2 1 2 5/5 5.4 ± 2.0 0/5 2.5 ± 0.1 0/5 35.5 ± 0.8
99-624 DP-C10 E A E 4 2 1 3 4/4 6.8 ± 2.5 1/4 3.2 ± 1.3 1/4 35.7 ± 2.1
99-625 DP-D8 E AB E 4 2 1 4 5/5 8.1 ± 0.2 3/5 4.0 ± 1.6 2/5 34.1 ± 3.3
99-645 DP-C4 E A E 5 2 1 4 5/5 8.3 ± 0.4 4/5 4.7 ± 1.9 2/5 34.1 ± 2.0
99-736 DP-C7 E AB E 4 2 1 2 7/10 6.1 ± 2.5 3/10 3.2 ± 1.1 2/10 34.3 ± 2.3
99-738 DP-B5 E A E 4 2 1 5 5/5 8.3 ± 0.3 5/5 5.4 ± 1.0 2/5 33.5 ± 1.3
99-742 DP-A9 E AB E 4 2 1 4 5/5 6.5 ± 2.0 3/5 4.4 ± 1.7 3/5 33.7 ± 1.7
99-743 DP-B6 E B E 3 1 1 3 4/5 7.3 ± 2.5 0/5 2.5 ± 0.0 0/5 35.1 ± 1.6
99-779 DP-D2 E A E 6 0 2 1 3 5/5 6.8 ± 2.5 1/5 3.4 ± 0.5 1/5 34.4 ± 2.4
99-780 DP-E1 E A E 5 1 1 3 5/5 7.2 ± 1.6 1/5 2.7 ± 0.5 0/5 35.4 ± 1.9
99-796 DP-E7 E AB E 4 2 1 4 5/5 8.4 ± 0.3 5/5 4.5 ± 1.4 0/5 35.2 ± 2.2
ATCC 29307 C B C 4 5/5 8.1 ± 0.0 3/5 5.0 ± 2.6 0/5 34.6 ± 1.5
ATL-9572 C A E 3 2 1 1 0/5 3.0 ± 0.0 0/5 2.5 ± 0.0 0/5 35.4 ± 1.0
ATL-9580 C B C 3 1 2 5 5/5 8.3 ± 0.2 5/5 5.8 ± 0.0 5/5 29.6 ± 0.0
ATL-9824 C B C 4 1 2 2 3/5 6.1 ± 2.9 2/5 3.4 ± 1.2 1/5 34.7 ± 2.0
CDC 9003-97 (FLA 9509) C B C 9 1 2 4 5/5 8.3 ± 0.1 5/5 5.1 ± 0.5 5/5 29.7 ± 1.0
CDC 9005-97 (DAL 7-9087) C A E 3 2 1 1 3 9/9 7.0 ± 1.4 3/9 2.6 ± 0.3 0/10 36.0 ± 0.6
CDC 9030-95 (ORL 1506) FLDHRS-383C C AB E 4 2 2 1 5 10/10 7.8 ± 0.3 10/10 5.7 ± 1.1 10/10 29.2 ± 1.4
CDC 9031-96 (ATL 6-1306) C AB E 4 2 1 3 5/5 6.9 ± 1.9 3/10 2.7 ± 0.6 2/10 35.3 ± 2.6
CDC 9032-95 (ORL-8074) FLDHRS-407C C B C 3 1 2 4 5/5 7.9 ± 0.5 5/5 5.4 ± 0.1 5/5 29.9 ± 0.5
CDC 9038-96 (LOS 7318) C B C 2 1 1 2 2 5/5 6.1 ± 1.7 0/5 2.5 ± 0.0 0/5 34.9 ± 0.8
CDC 9053-96 (FLA 8869) C B C 9 1 2 2 4/5 4.9 ± 2.1 1/5 2.8 ± 0.7 0/5 35.5 ± 0.6
CDC 9060-96 (DAL 7-9002) C B C 4 2 2 5 5/5 7.6 ± 0.5 5/5 6.3 ± 1.0 5/5 29.6 ± 1.2
CDC 9062-96 (LOS 7343) C B C 9 1 1 2 4 10/10 8.1 ± 0.9 6/10 3.5 ± 1.4 4/10 33.4 ± 3.6
CDC 9067-96 (DAL 7-9000) C B C 9 1 2 4 5/5 7.9 ± 0.3 5/5 5.3 ± 1.1 4/5 31.8 ± 1.1
CDC 9070-96 (DAL 79040) C B C 4 1 2 2 3/5 5.9 ± 2.7 3/5 3.7 ± 1.2 2/5 34.0 ± 2.5
CDC 9074-96 (ATL 71491) C B C 9 1 2 5 5/5 8.2 ± 0.3 5/5 6.5 ± 1.4 5/5 27.9 ± 1.9
CDC 9075-96 (ATL 71503) C AB E 4 2 1 2 4/5 6.0 ± 2.5 2/5 3.7 ± 1.2 1/5 34.9 ± 3.3
CDC 9076-96 (ATL 71504) C B C 9 1 2 5 5/5 8.5 ± 0.1 5/5 5.4 ± 1.4 0/5 35.1 ± 2.1
CDC 9149-95 (NSV 5829) C AB E 4 2 1 4 5/5 8.0 ± 0.3 5/5 4.9 ± 1.5 3/5 33.0 ± 2.5
CDC 9340-95 (ORL 8324) FLDHRS-721C C B C 1 1 2 4 5/5 8.0 ± 0.3 4/5 4.2 ± 1.3 3/5 32.9 ± 3.2
CDC 9342-95 (LOS 6966) C B C 4 2 2 2 3/5 5.9 ± 2.6 0/5 2.5 ± 0.1 0/5 35.8 ± 1.1
CDC 9345-95 (DAL 6-5000) C B C NG 2 2 1 5/5 4.0 ± 1.3 1/5 2.6 ± 0.1 0/10 36.0 ± 0.5
CDC 9348-95 (NSV 5830) C AB E 4 2 1 5 5/5 8.1 ± 0.0 5/5 6.7 ± 0.2 4/5 31.1 ± 1.1
CDC 9349-95 (NSV 5736) C B C 3 1 2 5 5/5 8.3 ± 0.5 5/5 7.3 ± 0.9 4/5 31.6 ± 0.0
CDC 9352-94 (ATL 9823) C B C 1 1 2 4 5/5 8.4 ± 0.5 3/5 3.3 ± 0.8 0/5 37.3 ± 1.0
CMCP6 C B C NG 1 1 2 4 5/5 7.2 ± 0.3 5/5 4.3 ± 1.2 4/5 31.2 ± 2.0
FDOH 6325 C A E 7 0 4 7/10 6.5 ± 2.4 7/10 4.2 ± 1.2 6/10 31.3 ± 4.3
LL728 C B C NG 4 4/5 7.5 ± 2.1 4/5 4.8 ± 1.3 4/5 33.2 ± 1.9
MO6-24/O C B C 9 1 1 2 4 5/5 7.9 ± 0.1 5/5 5.2 ± 0.7 5/5 29.0 ± 2.1
MLT365 E B C 8 1 1/5 3.7 ± 1.7 1/5 2.5 ± 0.1
MLT367 E B C 8 1 2/6 3.5 ± 1.1 0/6 2.5 ± 0.0
MLT403 E B C NG 1 1/5 3.5 ± 1.1 0/5 2.5 ± 0.0
S1-10 E B C 9 1 2 2/5 5.1 ± 2.9 1/5 2.9 ± 1.1 0/5 37.5 ± 1.7
S1-13 E A E 6 1 4 5/5 8.1 ± 0.2 4/5 4.7 ± 1.9 4/5 32.5 ± 3.8
S1-8 E A E 4 0 2 0/5 4.5 ± 0.0 0/5 2.5 ± 0.0 0/5 37.4 ± 0.5
S2-10 E A E 3 0 4 5/5 8.3 ± 0.4 2/5 3.4 ± 1.7 2/5 35.8 ± 3.9
S2-20 E B C 3 1 4 4/4 8.2 ± 0.3 4/4 4.8 ± 0.7 4/4 32.6 ± 3.4
S2-22 E B C 9 1 3 4/5 6.8 ± 1.9 1/5 2.5 ± 0.7 0/5 38.3 ± 0.3
S3-16 E B C 3 0 1 1/5 3.2 ± 0.0 0/5 2.4 ± 0.2 0/5 36.8 ± 0.6
S3-5 E A E 4 0 4 5/5 7.5 ± 1.3 4/5 4.7 ± 1.1 2/5 34.5 ± 2.1
VV1009 C B C NG 4 4/5 6.9 ± 2.3 4/5 4.6 ± 1.3 3/5 34.3 ± 3.1
YJ016 C B C 2 2 1 2 5 5/5 7.7 ± 0.3 8/8 5.7 ± 0.2 8/8 29.1 ± 3.6
a

C, clinical; E, environmental.

b

Number of mice with detectable skin infection, liver infection, or a body temperature of less than 33°C over the total number of mice inoculated.

c

Mean ± standard deviation.

d

NG, not grouped. No other strains exhibited greater than 85% homology.